Marian Muchada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marian Muchada has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Marta Rubiera
Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain
13 shared publications - Alvaro Garcia-Tornel
Stroke Unit, Vall d’Hebron University Hospital, Barcelona, Spain
11 shared publications - Jorge Pagola
Vall d'Hebrón University Hospital
11 shared publications - Marc Ribo
Stroke Unit. Neurology, Hospital Vall d’Hebron, Barcelona, Spain
11 shared publications - Carlos A. Molina
Stroke Unit, Hospital Vall d’Hebron, Barcelona, Spain (C.A.M.).
10 shared publications - David Rodriguez-Luna
Vall d'Hebrón University Hospital
10 shared publications
Latest Publications
- 18 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Standardized Ultrafast Transcranial Ultrasound Acquisition in Acute Stroke: The HYPER‐AI‐SCAN Pilot Study With Exploratory Artificial Intelligence Analysis
Background: Intracerebral hemorrhage requires rapid mechanism‐specific treatment, yet early stroke triage relies on clinical severity scales that do not reliably distinguish hemorrhage from ischemic stroke. We assessed the feasibility of a standardized ultrafast transcranial ultrasound protocol designed to support subsequent artificial intelligence (AI)‐based intracerebral hemorrhage detection. Methods: HYPER‐AI‐SCAN (Hyper‐Acute AI‐Assisted Sonographic Cerebral Hemorrhage Assessment Network) was a single‐center prospective feasibility study with embedded exploratory AI analysis. Between March and December 2025, 102 adults with acute computed tomography (CT)‐confirmed stroke were prospectively enrolled according to trained operator availability. Primary feasibility outcomes were protocol completion, operator‐rated adequate transtemporal windows, and acquisition time. In patients with retrievable paired baseline CT, exploratory AI analyses compared CT‐only, ultrasound‐only, and cross‐modal CT‐guided ultrasound models using patient‐level area under the receiver operating characteristic curve, sensitivity, and specificity. Results: Two patients were excluded after acquisition because insonation depth was <19 cm, yielding 100 evaluable patients (33 intracerebral hemorrhage; 67 ischemic stroke). The protocol was completed in all evaluable patients; adequate transtemporal windows were identified in 87%, and median acquisition time was 22 seconds (interquartile range, 13–31). Paired baseline CT images were available in 91 patients. Mean area under the receiver operating characteristic curve was 0.86 (SD, 0.07) for the CT‐only model, 0.85 (SD, 0.14) for the ultrasound‐only model, and 0.92 (SD, 0.07) for the cross‐modal model. Conclusions: Standardized ultrafast transcranial ultrasound acquisition was feasible at the bedside in acute stroke and generated brief cine‐loops suitable for exploratory AI development. Multicenter external validation is required before diagnostic or triage application. Registration Information: Clinicaltrials.gov. Identifier: NCT07319013.
- 18 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Standardized Ultrafast Transcranial Ultrasound Acquisition in Acute Stroke: The HYPER‐AI‐SCAN Pilot Study With Exploratory Artificial Intelligence Analysis
Background: Intracerebral hemorrhage requires rapid mechanism‐specific treatment, yet early stroke triage relies on clinical severity scales that do not reliably distinguish hemorrhage from ischemic stroke. We assessed the feasibility of a standardized ultrafast transcranial ultrasound protocol designed to support subsequent artificial intelligence (AI)‐based intracerebral hemorrhage detection. Methods: HYPER‐AI‐SCAN (Hyper‐Acute AI‐Assisted Sonographic Cerebral Hemorrhage Assessment Network) was a single‐center prospective feasibility study with embedded exploratory AI analysis. Between March and December 2025, 102 adults with acute computed tomography (CT)‐confirmed stroke were prospectively enrolled according to trained operator availability. Primary feasibility outcomes were protocol completion, operator‐rated adequate transtemporal windows, and acquisition time. In patients with retrievable paired baseline CT, exploratory AI analyses compared CT‐only, ultrasound‐only, and cross‐modal CT‐guided ultrasound models using patient‐level area under the receiver operating characteristic curve, sensitivity, and specificity. Results: Two patients were excluded after acquisition because insonation depth was <19 cm, yielding 100 evaluable patients (33 intracerebral hemorrhage; 67 ischemic stroke). The protocol was completed in all evaluable patients; adequate transtemporal windows were identified in 87%, and median acquisition time was 22 seconds (interquartile range, 13–31). Paired baseline CT images were available in 91 patients. Mean area under the receiver operating characteristic curve was 0.86 (SD, 0.07) for the CT‐only model, 0.85 (SD, 0.14) for the ultrasound‐only model, and 0.92 (SD, 0.07) for the cross‐modal model. Conclusions: Standardized ultrafast transcranial ultrasound acquisition was feasible at the bedside in acute stroke and generated brief cine‐loops suitable for exploratory AI development. Multicenter external validation is required before diagnostic or triage application. Registration Information: Clinicaltrials.gov. Identifier: NCT07319013.
- 1 April 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (4) , 1075-1085
Balancing Innovation and Responsibility: Ethical and Privacy Challenges in Stroke Digital Health
Digital health solutions are being increasingly used to support care delivery across various medical fields. In stroke care, technology has contributed to enhancing prehospital workflows, facilitating communication among health care professionals, and enabling fast-track systems for hyperacute stroke management. Furthermore, digital tools are used to improve etiological diagnosis and allow for more tailored long-term follow-up of stroke patient survivors. Digital technologies have become an integral part of stroke management, and the rapid evolution of artificial intelligence continues to accelerate and drive this transformation. However, ethical and privacy considerations are central and represent a major challenge for the design and implementation of digital solutions in health care. Health care professionals involved in stroke care require a clear understanding of the digital tools they use, including their potential, limitations, and biases, and must be aware of the responsibilities inherent in relying on such systems for treatment decisions and outcome prediction. This topical review aims to examine current digital innovations in stroke care, with a particular focus on the key ethical and privacy challenges they raise.
- 1 April 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (4) , 1075-1085
Balancing Innovation and Responsibility: Ethical and Privacy Challenges in Stroke Digital Health
Digital health solutions are being increasingly used to support care delivery across various medical fields. In stroke care, technology has contributed to enhancing prehospital workflows, facilitating communication among health care professionals, and enabling fast-track systems for hyperacute stroke management. Furthermore, digital tools are used to improve etiological diagnosis and allow for more tailored long-term follow-up of stroke patient survivors. Digital technologies have become an integral part of stroke management, and the rapid evolution of artificial intelligence continues to accelerate and drive this transformation. However, ethical and privacy considerations are central and represent a major challenge for the design and implementation of digital solutions in health care. Health care professionals involved in stroke care require a clear understanding of the digital tools they use, including their potential, limitations, and biases, and must be aware of the responsibilities inherent in relying on such systems for treatment decisions and outcome prediction. This topical review aims to examine current digital innovations in stroke care, with a particular focus on the key ethical and privacy challenges they raise.
- Open Access
- 1 March 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (3)
HARMONICS: feasibility of a holistic value-based care hybrid programme that maximises clinical outcomes after stroke
Introduction: The increasing number of stroke survivors underscores the need for coordinated post-discharge care and systematic outcome monitoring. HARMONICS aimed to provide standardised follow-up, integrating clinician-reported (CROMs) and patient-reported outcomes (PROMs) into a value-based care model. Patients and methods: Using lean methodology, post-stroke care pathways were mapped, and a harmonised workflow was implemented across 6 comprehensive stroke centres (CSCs) in Spain and Portugal. Consecutive patients discharged home or to socio-rehabilitation facilities with an mRS < 5 were offered participation. Follow-up was conducted via a smartphone app or telephone, enabling bidirectional communication with a case manager for health education, vital sign monitoring and PROMs collection. Feasibility required meeting 4 predefined indicators: inclusion > 60%, 3-month retention > 75%, PROMs completion > 60% and satisfaction > 70% measured by patient-reported experience measurement (PREM). Secondary analyses compared outcomes with historical cohorts. Results: Between 2022 and 2024, 4209 patients were recruited (40.2% women; median age 73 [IQR 62–81]; 75.6% ischaemic; median admission NIHSS 3 [1–6]; median discharge mRS 2 [1–3]). App use occurred in 59.9% (56% independently). Feasibility was achieved for inclusion (82.8%), retention (84.6%) and satisfaction (72.9%), but PROMs completion was 53.7% at 90 days. Despite mild severity, many reported suboptimal PROMs at 3 months, improving modestly by 1 year. Compared with historical controls, HARMONICS patients showed a better 3-month mRS distribution (OR 1.124; 95% CI, 1.042–1.213; P = .0026) and improved PROMs (P < .05). Discussion and Conclusion: HARMONICS is a feasible multicentre value-based follow-up model that promotes education, engagement and self-responsibility, with high rates of healthcare satisfaction reported by stroke survivors.
- 1 March 2026
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (3)
Open AccessHARMONICS: feasibility of a holistic value-based care hybrid programme that maximises clinical outcomes after stroke
Introduction: The increasing number of stroke survivors underscores the need for coordinated post-discharge care and systematic outcome monitoring. HARMONICS aimed to provide standardised follow-up, integrating clinician-reported (CROMs) and patient-reported outcomes (PROMs) into a value-based care model. Patients and methods: Using lean methodology, post-stroke care pathways were mapped, and a harmonised workflow was implemented across 6 comprehensive stroke centres (CSCs) in Spain and Portugal. Consecutive patients discharged home or to socio-rehabilitation facilities with an mRS < 5 were offered participation. Follow-up was conducted via a smartphone app or telephone, enabling bidirectional communication with a case manager for health education, vital sign monitoring and PROMs collection. Feasibility required meeting 4 predefined indicators: inclusion > 60%, 3-month retention > 75%, PROMs completion > 60% and satisfaction > 70% measured by patient-reported experience measurement (PREM). Secondary analyses compared outcomes with historical cohorts. Results: Between 2022 and 2024, 4209 patients were recruited (40.2% women; median age 73 [IQR 62–81]; 75.6% ischaemic; median admission NIHSS 3 [1–6]; median discharge mRS 2 [1–3]). App use occurred in 59.9% (56% independently). Feasibility was achieved for inclusion (82.8%), retention (84.6%) and satisfaction (72.9%), but PROMs completion was 53.7% at 90 days. Despite mild severity, many reported suboptimal PROMs at 3 months, improving modestly by 1 year. Compared with historical controls, HARMONICS patients showed a better 3-month mRS distribution (OR 1.124; 95% CI, 1.042–1.213; P = .0026) and improved PROMs (P < .05). Discussion and Conclusion: HARMONICS is a feasible multicentre value-based follow-up model that promotes education, engagement and self-responsibility, with high rates of healthcare satisfaction reported by stroke survivors.
- Open Access
ESUS-AI: a machine learning framework to estimate the most likely embolic source in embolic stroke of undetermined source
Background and Purpose: Embolic stroke of undetermined source (ESUS) emains a major diagnostic challenge in vascular neurology, as a substantial proportion of patients lack an identifiable embolic source despite standardized diagnostic workup. The failure of empiric anticoagulation strategies highlights the need for individualized, mechanism-oriented risk stratification. We aimed to develop a machine learning–based framework to estimate the most likely embolic source in ESUS using routinely available clinical data. Methods: We retrospectively analyzed consecutive ESUS patients admitted to the Stroke Unit of Vall d’Hebron Hospital between 2020 and 2024. Three supervised machine learning models (XGBoost, Random Forest, and regularized logistic regression) were trained to independently predict the presence of left atrial enlargement (LAE), left ventricular dysfunction or akinesia (LVD), and complex aortic plaques (AP), based on demographic, clinical, laboratory, and imaging variables available at diagnosis. Model interpretability was assessed using permutation importance and SHAP analyses. Results: Among 1,741 ESUS patients (mean age 71.5±14.6 years; 48.3% women), LAE was present in 40.5%, AP in 11.0%, and LVD in 6.5%. XGBoost achieved the best overall performance across targets (PR-AUC: 0.71 for LAE, 0.29 for AP, 0.44 for LVD). Distinct and biologically coherent risk profiles emerged. LAE was driven by older age, elevated NT-proBNP, higher stroke severity, and a non-linear association with cholesterol. AP was associated with advanced age and traditional vascular risk factors. LVD showed a cardiomyopathic pattern characterized by elevated NT-proBNP, younger age, male sex, and severe strokes. Conclusions: A machine learning–based approach can provide probabilistic, mechanism-oriented stratification in ESUS, capturing non-linear interactions among routinely available variables. This framework may support clinicians in prioritizing targeted diagnostic pathways and tailoring secondary prevention strategies, pending external validation.
Open AccessESUS-AI: a machine learning framework to estimate the most likely embolic source in embolic stroke of undetermined source
Background and Purpose: Embolic stroke of undetermined source (ESUS) emains a major diagnostic challenge in vascular neurology, as a substantial proportion of patients lack an identifiable embolic source despite standardized diagnostic workup. The failure of empiric anticoagulation strategies highlights the need for individualized, mechanism-oriented risk stratification. We aimed to develop a machine learning–based framework to estimate the most likely embolic source in ESUS using routinely available clinical data. Methods: We retrospectively analyzed consecutive ESUS patients admitted to the Stroke Unit of Vall d’Hebron Hospital between 2020 and 2024. Three supervised machine learning models (XGBoost, Random Forest, and regularized logistic regression) were trained to independently predict the presence of left atrial enlargement (LAE), left ventricular dysfunction or akinesia (LVD), and complex aortic plaques (AP), based on demographic, clinical, laboratory, and imaging variables available at diagnosis. Model interpretability was assessed using permutation importance and SHAP analyses. Results: Among 1,741 ESUS patients (mean age 71.5±14.6 years; 48.3% women), LAE was present in 40.5%, AP in 11.0%, and LVD in 6.5%. XGBoost achieved the best overall performance across targets (PR-AUC: 0.71 for LAE, 0.29 for AP, 0.44 for LVD). Distinct and biologically coherent risk profiles emerged. LAE was driven by older age, elevated NT-proBNP, higher stroke severity, and a non-linear association with cholesterol. AP was associated with advanced age and traditional vascular risk factors. LVD showed a cardiomyopathic pattern characterized by elevated NT-proBNP, younger age, male sex, and severe strokes. Conclusions: A machine learning–based approach can provide probabilistic, mechanism-oriented stratification in ESUS, capturing non-linear interactions among routinely available variables. This framework may support clinicians in prioritizing targeted diagnostic pathways and tailoring secondary prevention strategies, pending external validation.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1581-1586
Impact of Direct Transfer to Angiography Suite on Treatment Time Metrics in Patients With Acute Intracerebral Hemorrhage
BACKGROUND: Shorter times to initiate antihypertensive and anticoagulation reversal treatments enhance their benefits in acute intracerebral hemorrhage (ICH). Improving workflows to optimize time performance metrics is strongly advocated. We aimed to evaluate the impact of direct transfer to angiography suite (DTAS) on time metrics for antihypertensive and anticoagulation reversal treatments in patients with stroke with suspected large vessel occlusion whose final diagnosis was ICH. METHODS: We conducted a single-center, retrospective, observational cohort study using prospectively collected data from patients with ICH 4 and in-hospital National Institutes of Health Stroke Scale score >10) followed either direct transfer to computed tomography (DTCT) or DTAS protocol based on angiosuite availability. We compared door-to-needle times for initiating antihypertensive (primary outcome) and anticoagulation reversal treatments between both workflows. RESULTS: Among 220 patients with ICH (mean age, 73.0±13.6 years; 131 [59.5%] male), 199 (90.5%) followed the DTCT protocol and 21 (9.5%) followed the DTAS protocol. Door-to-imaging time was shorter in the DTCT group than in the DTAS group (11 [7–17] versus 15 [12–20] minutes; P =0.013). Antihypertensive treatment was initiated in 168 (76.4%) patients, with the DTCT group having shorter door-to-needle times (20 [15–26] versus 30 [18–40] minutes; P =0.002). The anticoagulation reversal was administered to 34 (87.2%) of 39 anticoagulated patients, with the DTCT group achieving shorter door-to-needle times (28 [22–38] versus 58 [39–78] minutes; P =0.047). Time-to-event analysis showed that the DTCT group had a higher probability of initiating antihypertensive ( P =0.001) and anticoagulation reversal ( P =0.014) treatments sooner compared with the DTSA group. CONCLUSIONS: Patients with ICH following the DTAS workflow, without tailored actions, present longer door-to-needle times to initiate antihypertensive and anticoagulation reversal treatments compared with those following the DTCT workflow protocol.
- 1 June 2025
- Published by Wolters Kluwer Health in Stroke
- Vol. 56 (6) , 1581-1586
Impact of Direct Transfer to Angiography Suite on Treatment Time Metrics in Patients With Acute Intracerebral Hemorrhage
BACKGROUND: Shorter times to initiate antihypertensive and anticoagulation reversal treatments enhance their benefits in acute intracerebral hemorrhage (ICH). Improving workflows to optimize time performance metrics is strongly advocated. We aimed to evaluate the impact of direct transfer to angiography suite (DTAS) on time metrics for antihypertensive and anticoagulation reversal treatments in patients with stroke with suspected large vessel occlusion whose final diagnosis was ICH. METHODS: We conducted a single-center, retrospective, observational cohort study using prospectively collected data from patients with ICH 4 and in-hospital National Institutes of Health Stroke Scale score >10) followed either direct transfer to computed tomography (DTCT) or DTAS protocol based on angiosuite availability. We compared door-to-needle times for initiating antihypertensive (primary outcome) and anticoagulation reversal treatments between both workflows. RESULTS: Among 220 patients with ICH (mean age, 73.0±13.6 years; 131 [59.5%] male), 199 (90.5%) followed the DTCT protocol and 21 (9.5%) followed the DTAS protocol. Door-to-imaging time was shorter in the DTCT group than in the DTAS group (11 [7–17] versus 15 [12–20] minutes; P =0.013). Antihypertensive treatment was initiated in 168 (76.4%) patients, with the DTCT group having shorter door-to-needle times (20 [15–26] versus 30 [18–40] minutes; P =0.002). The anticoagulation reversal was administered to 34 (87.2%) of 39 anticoagulated patients, with the DTCT group achieving shorter door-to-needle times (28 [22–38] versus 58 [39–78] minutes; P =0.047). Time-to-event analysis showed that the DTCT group had a higher probability of initiating antihypertensive ( P =0.001) and anticoagulation reversal ( P =0.014) treatments sooner compared with the DTSA group. CONCLUSIONS: Patients with ICH following the DTAS workflow, without tailored actions, present longer door-to-needle times to initiate antihypertensive and anticoagulation reversal treatments compared with those following the DTCT workflow protocol.
- 1 May 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (5) , 1200-1209
PRERISK: A Personalized, Artificial Intelligence–Based and Statistically–Based Stroke Recurrence Predictor for Recurrent Stroke
BACKGROUND: Predicting stroke recurrence for individual patients is difficult, but individualized prediction may improve stroke survivors’ engagement in self-care. We developed PRERISK: a statistical and machine learning classifier to predict individual risk of stroke recurrence. METHODS: We analyzed clinical and socioeconomic data from a prospectively collected public health care–based data set of 41 975 patients admitted with stroke diagnosis in 88 public health centers over 6 years (2014–2020) in Catalonia-Spain. A new stroke diagnosis at least 24 hours after the index event was considered as a recurrent stroke, which was considered as our outcome of interest. We trained several supervised machine learning models to provide individualized risk over time and compared them with a Cox regression model. Models were trained to predict early, late, and long-term recurrence risk, within 90, 91 to 365, and >365 days, respectively. C statistics and area under the receiver operating characteristic curve were used to assess the accuracy of the models. RESULTS: Overall, 16.21% (5932 of 36 114) of patients had stroke recurrence during a median follow-up of 2.69 years. The most powerful predictors of stroke recurrence were time from previous stroke, Barthel Index, atrial fibrillation, dyslipidemia, age, diabetes, and sex, which were used to create a simplified model with similar performance, together with modifiable vascular risk factors (glycemia, body mass index, high blood pressure, cholesterol, tobacco dependence, and alcohol abuse). The areas under the receiver operating characteristic curve were 0.76 (95% CI, 0.74–0.77), 0.60 (95% CI, 0.58–0.61), and 0.71 (95% CI, 0.69–0.72) for early, late, and long-term recurrence risk, respectively. The areas under the receiver operating characteristic curve of the Cox risk class probability were 0.73 (95% CI, 0.72–0.75), 0.59 (95% CI, 0.57–0.61), and 0.67 (95% CI, 0.66–0.70); machine learning approaches (random forest and AdaBoost) showed statistically significant improvement ( P <0.05) over the Cox model for the 3 recurrence time periods. Stroke recurrence curves can be simulated for each patient under different degrees of control of modifiable factors. CONCLUSIONS: PRERISK is a novel approach that provides a personalized and fairly accurate risk prediction of stroke recurrence over time. The model has the potential to incorporate dynamic control of risk factors.
- 1 May 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (5) , 1200-1209
PRERISK: A Personalized, Artificial Intelligence–Based and Statistically–Based Stroke Recurrence Predictor for Recurrent Stroke
BACKGROUND: Predicting stroke recurrence for individual patients is difficult, but individualized prediction may improve stroke survivors’ engagement in self-care. We developed PRERISK: a statistical and machine learning classifier to predict individual risk of stroke recurrence. METHODS: We analyzed clinical and socioeconomic data from a prospectively collected public health care–based data set of 41 975 patients admitted with stroke diagnosis in 88 public health centers over 6 years (2014–2020) in Catalonia-Spain. A new stroke diagnosis at least 24 hours after the index event was considered as a recurrent stroke, which was considered as our outcome of interest. We trained several supervised machine learning models to provide individualized risk over time and compared them with a Cox regression model. Models were trained to predict early, late, and long-term recurrence risk, within 90, 91 to 365, and >365 days, respectively. C statistics and area under the receiver operating characteristic curve were used to assess the accuracy of the models. RESULTS: Overall, 16.21% (5932 of 36 114) of patients had stroke recurrence during a median follow-up of 2.69 years. The most powerful predictors of stroke recurrence were time from previous stroke, Barthel Index, atrial fibrillation, dyslipidemia, age, diabetes, and sex, which were used to create a simplified model with similar performance, together with modifiable vascular risk factors (glycemia, body mass index, high blood pressure, cholesterol, tobacco dependence, and alcohol abuse). The areas under the receiver operating characteristic curve were 0.76 (95% CI, 0.74–0.77), 0.60 (95% CI, 0.58–0.61), and 0.71 (95% CI, 0.69–0.72) for early, late, and long-term recurrence risk, respectively. The areas under the receiver operating characteristic curve of the Cox risk class probability were 0.73 (95% CI, 0.72–0.75), 0.59 (95% CI, 0.57–0.61), and 0.67 (95% CI, 0.66–0.70); machine learning approaches (random forest and AdaBoost) showed statistically significant improvement ( P <0.05) over the Cox model for the 3 recurrence time periods. Stroke recurrence curves can be simulated for each patient under different degrees of control of modifiable factors. CONCLUSIONS: PRERISK is a novel approach that provides a personalized and fairly accurate risk prediction of stroke recurrence over time. The model has the potential to incorporate dynamic control of risk factors.
- 1 April 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (4) , 840-848
Radial Versus Femoral Access for Mechanical Thrombectomy in Patients With Stroke: A Noninferiority Randomized Clinical Trial
BACKGROUND: Transfemoral access is predominantly used for mechanical thrombectomy in patients with stroke with a large vessel occlusion. Following the interventional cardiology guidelines, routine transradial access has been proposed as an alternative, although its safety and efficacy remain controversial. We aim to explore the noninferiority of radial access in terms of final recanalization. METHODS: The study was an investigator-initiated, single-center, evaluator-blinded, noninferiority randomized clinical trial. Patients with stroke undergoing mechanical thrombectomy, with a patent femoral artery and a radial artery diameter ≥2.5 mm, were randomly assigned (1:1) to either transradial (60 patients) or transfemoral access (60 patients). The primary binary outcome was the successful recanalization (expanded Treatment in Cerebral Ischemia score, 2b–3) assigned by blinded evaluators. We established a noninferiority margin of −13.2%, considering an acceptable reduction of 15% in the expected recanalization rates. RESULTS: From September 2021 to July 2023, 120 patients were randomly assigned and 116 (58 transradial access and 58 transfemoral access) with confirmed intracranial occlusion on the initial angiogram were included in the intention-to-treat analysis. Successful recanalization was achieved in 51 (87.9%) patients assigned to transfemoral access and in 56/58 (96.6%) patients assigned to transradial (adjusted 1 side risk difference [RD], −5.0% [95% CI, −6.61% to +13.1%]) showing noninferiority of transradial access. Median time from angiosuite arrival to first pass (femoral, 30 [interquartile range, 25–37] minutes versus radial: 41 [interquartile range, 33–62] minutes; P P P =0.751). CONCLUSIONS: Among patients who underwent mechanical thrombectomy, transradial access was noninferior to transfemoral access in terms of final recanalization. Procedural delays may favor transfemoral access as the default first-line approach. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05225636.
- 1 April 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (4) , 840-848
Radial Versus Femoral Access for Mechanical Thrombectomy in Patients With Stroke: A Noninferiority Randomized Clinical Trial
BACKGROUND: Transfemoral access is predominantly used for mechanical thrombectomy in patients with stroke with a large vessel occlusion. Following the interventional cardiology guidelines, routine transradial access has been proposed as an alternative, although its safety and efficacy remain controversial. We aim to explore the noninferiority of radial access in terms of final recanalization. METHODS: The study was an investigator-initiated, single-center, evaluator-blinded, noninferiority randomized clinical trial. Patients with stroke undergoing mechanical thrombectomy, with a patent femoral artery and a radial artery diameter ≥2.5 mm, were randomly assigned (1:1) to either transradial (60 patients) or transfemoral access (60 patients). The primary binary outcome was the successful recanalization (expanded Treatment in Cerebral Ischemia score, 2b–3) assigned by blinded evaluators. We established a noninferiority margin of −13.2%, considering an acceptable reduction of 15% in the expected recanalization rates. RESULTS: From September 2021 to July 2023, 120 patients were randomly assigned and 116 (58 transradial access and 58 transfemoral access) with confirmed intracranial occlusion on the initial angiogram were included in the intention-to-treat analysis. Successful recanalization was achieved in 51 (87.9%) patients assigned to transfemoral access and in 56/58 (96.6%) patients assigned to transradial (adjusted 1 side risk difference [RD], −5.0% [95% CI, −6.61% to +13.1%]) showing noninferiority of transradial access. Median time from angiosuite arrival to first pass (femoral, 30 [interquartile range, 25–37] minutes versus radial: 41 [interquartile range, 33–62] minutes; P P P =0.751). CONCLUSIONS: Among patients who underwent mechanical thrombectomy, transradial access was noninferior to transfemoral access in terms of final recanalization. Procedural delays may favor transfemoral access as the default first-line approach. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05225636.
- Open Access
- 20 February 2024
- Published by Wiley in Journal of Clinical Nursing
- Vol. 33 (4) , 1398-1408
Enhancing blood pressure management protocol implementation in patients with acute intracerebral haemorrhage through a nursing‐led approach: A retrospective cohort study
Aim: To evaluate the impact of nurse care changes in implementing a blood pressure management protocol on achieving rapid, intensive and sustained blood pressure reduction in acute intracerebral haemorrhage patients.Design: Retrospective cohort study of prospectively collected data over 6 years.Methods: Intracerebral haemorrhage patients within 6 h and systolic blood pressure ≥ 150 mmHg followed a rapid (starting treatment at computed tomography suite with a target achievement goal of ≤60 min), intensive (target systolic blood pressure < 140 mmHg) and sustained (maintaining target stability for 24 h) blood pressure management plan. We differentiated six periods: P1, stroke nurse at computed tomography suite (baseline period); P2, antihypertensive titration by stroke nurse; P3, retraining by neurologists; P4, integration of a stroke advanced practice nurse; P5, after COVID‐19 impact; and P6, retraining by stroke advanced practice nurse. Outcomes included first‐hour target achievement (primary outcome), tomography‐to‐treatment and treatment‐to‐target times, first‐hour maximum dose of antihypertensive treatment and 6‐h and 24‐h systolic blood pressure variability.Results: Compared to P1, antihypertensive titration by stroke nurses (P2) reduced treatment‐to‐target time and increased the rate of first‐hour target achievement, retraining of stroke nurses by neurologists (P3) maintained a higher rate of first‐hour target achievement and the integration of a stroke advanced practice nurse (P4) reduced both 6‐h and 24‐h systolic blood pressure variability. However, 6‐h systolic blood pressure variability increased from P4 to P5 following the impact of the COVID‐19 pandemic. Finally, compared to P1, retraining of stroke nurses by stroke advanced practice nurse (P6) reduced tomography‐to‐treatment time and increased the first‐hour maximum dose of antihypertensive treatment.Conclusion: Changes in nursing care and continuous education can significantly enhance the time metrics and blood pressure outcomes in acute intracerebral haemorrhage patients.Reporting Method: STROBE guidelines.Patient and Public Contribution: No Patient or Public Contribution.
- 20 February 2024
- Published by Wiley in Journal of Clinical Nursing
- Vol. 33 (4) , 1398-1408
Open AccessEnhancing blood pressure management protocol implementation in patients with acute intracerebral haemorrhage through a nursing‐led approach: A retrospective cohort study
Aim: To evaluate the impact of nurse care changes in implementing a blood pressure management protocol on achieving rapid, intensive and sustained blood pressure reduction in acute intracerebral haemorrhage patients.Design: Retrospective cohort study of prospectively collected data over 6 years.Methods: Intracerebral haemorrhage patients within 6 h and systolic blood pressure ≥ 150 mmHg followed a rapid (starting treatment at computed tomography suite with a target achievement goal of ≤60 min), intensive (target systolic blood pressure < 140 mmHg) and sustained (maintaining target stability for 24 h) blood pressure management plan. We differentiated six periods: P1, stroke nurse at computed tomography suite (baseline period); P2, antihypertensive titration by stroke nurse; P3, retraining by neurologists; P4, integration of a stroke advanced practice nurse; P5, after COVID‐19 impact; and P6, retraining by stroke advanced practice nurse. Outcomes included first‐hour target achievement (primary outcome), tomography‐to‐treatment and treatment‐to‐target times, first‐hour maximum dose of antihypertensive treatment and 6‐h and 24‐h systolic blood pressure variability.Results: Compared to P1, antihypertensive titration by stroke nurses (P2) reduced treatment‐to‐target time and increased the rate of first‐hour target achievement, retraining of stroke nurses by neurologists (P3) maintained a higher rate of first‐hour target achievement and the integration of a stroke advanced practice nurse (P4) reduced both 6‐h and 24‐h systolic blood pressure variability. However, 6‐h systolic blood pressure variability increased from P4 to P5 following the impact of the COVID‐19 pandemic. Finally, compared to P1, retraining of stroke nurses by stroke advanced practice nurse (P6) reduced tomography‐to‐treatment time and increased the first‐hour maximum dose of antihypertensive treatment.Conclusion: Changes in nursing care and continuous education can significantly enhance the time metrics and blood pressure outcomes in acute intracerebral haemorrhage patients.Reporting Method: STROBE guidelines.Patient and Public Contribution: No Patient or Public Contribution.
- Open Access
- 21 August 2023
- Published by BMJ
- Vol. 15 (Suppl 2) , A34.2-A34
P039/328 Endovascular treatment in cerebral venous thrombosis: safety and efficacy in an international two-center registry
Introduction The standard acute treatment of Cerebral Venous Thrombosis (CVT) is anticoagulation. After several uncontrolled studies and one randomized clinical trial, there is still uncertainty regarding the role of endovascular treatment (EVT) in this scenario. Aim of Study To evaluate safety and efficacy of EVT in CVT combined with best medical care. Methods We performed a retrospective analysis of an international two-center registry. Results EVT was performed in 20% (12/58) of CVT patients with a median time from diagnosis to treatment of 4.5h (1.25–28.5). Compared to medical therapy alone, EVT patients had higher baseline NIHSS [median 5.5 (2–17) vs 0 (0–3) p=0.004] and basal CT showed higher rates of intracerebral hemorrhage (41.7% vs 6.4%, p=0.006). EVT was performed using transjugular access in half of the patients and transfemoral access in the other half. Aspiration with large bore catheters was performed in every case with angioplasty in 7 out of 12 patients and stenting in 3 out of 12 patients. Recanalization was achieved in 75% of the patients with a median time from puncture to recanalization of 90 (74.3–157.5) minutes. No postprocedural complications were observed. We found a significant improvement from baseline to discharge median NIHSS in patients submitted to EVT [5.5 (2–17) vs 1(0–3.75) pConclusion In our series, endovascular treatments in CVT combined with anticoagulation was safe and efficacious as evidenced by angiographic findings and clinical improvement. Disclosure of Interest Nothing to disclose
- 21 August 2023
- Published by BMJ
- Vol. 15 (Suppl 2) , A34.2-A34
Open AccessP039/328 Endovascular treatment in cerebral venous thrombosis: safety and efficacy in an international two-center registry
Introduction The standard acute treatment of Cerebral Venous Thrombosis (CVT) is anticoagulation. After several uncontrolled studies and one randomized clinical trial, there is still uncertainty regarding the role of endovascular treatment (EVT) in this scenario. Aim of Study To evaluate safety and efficacy of EVT in CVT combined with best medical care. Methods We performed a retrospective analysis of an international two-center registry. Results EVT was performed in 20% (12/58) of CVT patients with a median time from diagnosis to treatment of 4.5h (1.25–28.5). Compared to medical therapy alone, EVT patients had higher baseline NIHSS [median 5.5 (2–17) vs 0 (0–3) p=0.004] and basal CT showed higher rates of intracerebral hemorrhage (41.7% vs 6.4%, p=0.006). EVT was performed using transjugular access in half of the patients and transfemoral access in the other half. Aspiration with large bore catheters was performed in every case with angioplasty in 7 out of 12 patients and stenting in 3 out of 12 patients. Recanalization was achieved in 75% of the patients with a median time from puncture to recanalization of 90 (74.3–157.5) minutes. No postprocedural complications were observed. We found a significant improvement from baseline to discharge median NIHSS in patients submitted to EVT [5.5 (2–17) vs 1(0–3.75) pConclusion In our series, endovascular treatments in CVT combined with anticoagulation was safe and efficacious as evidenced by angiographic findings and clinical improvement. Disclosure of Interest Nothing to disclose
- Open Access
PRERISK: A Personalized, daily and AI-based stroke recurrence predictor for patient awareness and treatment compliance
BACKGROUND The risk prediction of stroke recurrence for individual patients is a difficult task. Individualised prediction may enhance stroke survivors selfcare engagement. We have developed PRERISK: a statistical and Machine Learning (ML) classifier to predict individual stroke recurrence risk. METHODS We analysed clinical and socioeconomic data from a prospectively collected public healthcare-based dataset of 44623 patients admitted with stroke diagnosis in 88 public hospitals over 6 years in Catalonia-Spain. We trained several supervised-ML models to provide individualised risk along time and compared them with a Cox regression model. RESULTS Overall, 16% of patients presented a stroke recurrence along a median follow-up of 2.65 years. Models were trained for predicting early, late and long-term recurrence risk, within 90, 91-365 and >365 days, respectively. Most powerful predictors of stroke recurrence were time since index stroke, Barthel index, atrial fibrillation, dyslipidemia, haemoglobin and body mass index, which were used to create a simplified model with similar performance. The balanced AUROC were 0.77 (±0.01), 0.61 (±0.01) and 0.71 (±0.01) for early, late and long-term recurrence risk respectively (Cox risk class probability: 0.74(±0.01), 0.59(±0.01) and 0.68(±0.01), c-index 0.88). Overall, the ML approach showed statistically significant improvement over the Cox model. Stroke recurrence curves can be simulated for each patient under different degrees of control of modifiable factors. CONCLUSION PRERISK represents a novel approach that provides continuous, personalised and fairly accurate risk prediction of stroke recurrence along time according to the degree of modifiable risk factors control. What is new? Stroke recurrence is frequent after stroke despite advances in stroke treatments, and it is difficult to predict the individual risk of one patient. We have created PRERISK, a predictive model based on machine learning (ML) which provides individualised information of the probability of stroke recurrence and can be re-calculated according to risk factors control. What are the clinical implications? PRERISK information can be used as feedback for secondary prevention strategies and enhance patient engagement and treatment compliance. It could be scalable to optimise ML-based prevention strategies in other chronic conditions.
Open AccessPRERISK: A Personalized, daily and AI-based stroke recurrence predictor for patient awareness and treatment compliance
BACKGROUND The risk prediction of stroke recurrence for individual patients is a difficult task. Individualised prediction may enhance stroke survivors selfcare engagement. We have developed PRERISK: a statistical and Machine Learning (ML) classifier to predict individual stroke recurrence risk. METHODS We analysed clinical and socioeconomic data from a prospectively collected public healthcare-based dataset of 44623 patients admitted with stroke diagnosis in 88 public hospitals over 6 years in Catalonia-Spain. We trained several supervised-ML models to provide individualised risk along time and compared them with a Cox regression model. RESULTS Overall, 16% of patients presented a stroke recurrence along a median follow-up of 2.65 years. Models were trained for predicting early, late and long-term recurrence risk, within 90, 91-365 and >365 days, respectively. Most powerful predictors of stroke recurrence were time since index stroke, Barthel index, atrial fibrillation, dyslipidemia, haemoglobin and body mass index, which were used to create a simplified model with similar performance. The balanced AUROC were 0.77 (±0.01), 0.61 (±0.01) and 0.71 (±0.01) for early, late and long-term recurrence risk respectively (Cox risk class probability: 0.74(±0.01), 0.59(±0.01) and 0.68(±0.01), c-index 0.88). Overall, the ML approach showed statistically significant improvement over the Cox model. Stroke recurrence curves can be simulated for each patient under different degrees of control of modifiable factors. CONCLUSION PRERISK represents a novel approach that provides continuous, personalised and fairly accurate risk prediction of stroke recurrence along time according to the degree of modifiable risk factors control. What is new? Stroke recurrence is frequent after stroke despite advances in stroke treatments, and it is difficult to predict the individual risk of one patient. We have created PRERISK, a predictive model based on machine learning (ML) which provides individualised information of the probability of stroke recurrence and can be re-calculated according to risk factors control. What are the clinical implications? PRERISK information can be used as feedback for secondary prevention strategies and enhance patient engagement and treatment compliance. It could be scalable to optimise ML-based prevention strategies in other chronic conditions.